EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB)

被引：0

作者：

Schwarz, Kathleen B. ^{[1
]}

Bezerra, Jorge A. ^{[2
]}

Choe, Byung Ho ^{[3
,4
]}

Lin, Chuan-Hao ^{[5
]}

Abramov, Frida ^{[6
]}

Wang, Hongyuan ^{[6
]}

Liu, Yang ^{[6
]}

Flaherty, John F. ^{[6
]}

Pacurar, Daniela ^{[7
]}

Kim, Kyung Mo ^{[8
]}

Khaertynova, Ilsiyar ^{[9
]}

Shalimar ^{[10
]}

Wu, Jia-Feng ^{[11
]}

Tandon, Manish ^{[12
]}

Rosenthal, Philip ^{[13
]}

Morozov, Viacheslav ^{[14
]}

Sokal, Etienne M. ^{[15
]}

Chang, Mei Hwei ^{[16
,17
]}

机构：

[1] Univ Calif San Diego, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA

[2] Univ Texas Southwestern Med Ctr, Dallas, TX USA

[3] Kyungpook Natl Univ, Sch Med, Daegu, South Korea

[4] Kyungpook Natl Univ Childrens Hosp, Daegu, South Korea

[5] Childrens Hosp Los Angeles, Los Angeles, CA USA

[6] Gilead Sci Inc, Foster City, CA USA

[7] Carol Davila Univ Med & Pharm, Bucharest, Romania

[8] Univ Ulsan, Asan Med Ctr, Childrens Hosp, Seoul, South Korea

[9] Kazan State Med Univ, Kazan, Russia

[10] All India Inst Med Sci, Delhi, India

[11] Natl Taiwan Univ Hosp, Taipei, Taiwan

[12] MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India

[13] Univ Calif San Francisco, San Francisco, CA 94143 USA

[14] Hepatolog Med Co, Samara, Russia

[15] Clin Univ St Luc, Brussels, Belgium

[16] Natl Taiwan Univ, Taipei, Taiwan

[17] Children Hosp, Taipei, Taiwan

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1414C

引用

页码：S515 / S517

页数：3

共 50 条

[1] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
Schwarz, Kathleen B.
Bezerra, Jorge A.
Choe, Byung-Ho
Lin, Chuan-Hao
Abramov, Frida
Nguyen, Anh-Hoa
Liu, Yang
Flaherty, John F.
Pacurar, Daniela
Kim, Kyung Mo
Khaertynova, Ilsiyar
Shalimar
Wu, Jia-Feng
Tandon, Manish
Rosenthal, Philip
Morozov, Viacheslav
Sokal, Etienne
Chang, Mei-Hwei
HEPATOLOGY, 2022, 76 : S300 - S301
[2] SAFETY AND EFFICACY AT 1 YEAR IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB) RECEIVING TENOFOVIR ALAFENAMIDE (TAF)
Schwarz, Kathleen B.
Bezerra, Jorge
Choe, Byung-ho
Lin, Chuan-Hao
Abramov, Frida
Wang, Hongyuan
Liu, Yang
Flaherty, John F.
Pacurar, Daniela
Kim, Kyung Mo
Khaertynova, Ilsiyar
Shalimar
Wu, Jia-Feng
Tandon, Manish
Rosenthal, Philip
Morozov, Viacheslav
Sokal, Etinne
Chang, Mei-Hwei
GASTROENTEROLOGY, 2023, 164 (06) : S1237 - S1238
[3] Twenty Eight Day Safety and Efficacy of Tenofovir Alafenamide (TAF) Fumarate in Chronic Hepatitis B (CHB) Patients
Agarwal, Kosh
Fung, Scott K.
Nguyen, Tuan T.
Cheng, Wendy
Sicard, Eric
Ryder, Stephen D.
Flaherty, John F.
Lawson, Eileen
Zhao, Sally
Subramanian, Mani
McHutchison, John G.
Gane, Edward J.
Foster, Graham R.
HEPATOLOGY, 2013, 58 : 675A - 675A
[4] One-year safety and efficacy of tenofovir alafenamide (TAF) in chronic hepatitis B (CHB): a HEllenic multicenter ReAl-life CLInical Study (HERACLIS TAF)
Papatheodoridis, George
Mimidis, Konstantinos
Manolakopoulos, Spilios
Gatselis, Nikolaos
Goulis, Ioannis
Andreas, Kapatais
Manesis, Emmanouil
Vasileiadis, Themistoklis
Triantos, Christos
Samonakis, Demetrious N.
Sevastianos, Vasilis
Karapatanis, Stylianos
Elefsiniotis, Ioannis
Deutsch, Melanie
Mylopoulou, Theodora
Papatheodoridi, Margarita
Kranidioti, Hariklia
Agorastou, Polyxeni
Karaoulani, Theofanie
Kyriazidou, Anastasia
Zisimopoulos, Konstanitnos
Dalekos, George
JOURNAL OF HEPATOLOGY, 2021, 75 : S737 - S737
[5] NO DETECTED RESISTANCE TO TENOFOVIR ALAFENAMIDE (TAF) TREATMENT IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B (CHB): RESULTS FROM WEEK 24 PRIMARY ENDPOINT ANALYSIS
Schwarz, Kathleen B.
Bezerra, Jorge A.
Liu, Yang
Han, Dong
Xu, Simin
Yazdi, Tahmineh
May, Lindsey
Chang, Silvia
Martin, Ross
Mo, Hongmei
Abramov, Frida
Flaherty, John F.
Rosenthal, Philip
Chang, Mei-Hwei
HEPATOLOGY, 2022, 76 : S255 - S256
[6] NO DETECTED RESISTANCE TO TENOFOVIR ALAFENAMIDE ( TAF) THROUGH 96 WEEKS OF TREATMENT IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B
Rosenthal, Philip
Chang, Mei-Hwei
Bezerra, Jorge A.
Liu, Yang
Han, Dong
Xu, Simin
Marceau, Caleb
Yazdi, Tahmineh
May, Lindsey
Li, Robert
Manhas, Savrina
Ho, Pui Yan
Martinez, Clarissa
Peinovich, Nadine
Chang, Silvia
Martin, Ross
Maiorova, Evguenia
Mo, Hongmei
Abramov, Frida
Flaherty, John F.
Schwarz, Kathleen B.
HEPATOLOGY, 2023, 78 : S531 - S532
[7] EFFICACY AND RENAL SAFETY IN CHRONIC HEPATITIS B PATIENTS ON TENOFOVIR ALAFENAMIDE
Liang, Lilian Yan
Hui, Vicki Wing Ki
Yip, Terry Cheuk-Fung
Lai, Jimmy Che-To
Tse, Yee-Kit
Chan, Henry Lik Yuen
Wong, Vincent Wai-Sun
Wong, Grace Lai-Hung C.
HEPATOLOGY, 2023, 78 : S514 - S514
[8] WEEK 96 EFFICACY AND SAFETY RESULTS OF TENOFOVIR ALAFENAMIDE (TAF) COMPARING TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B (CHB), HBEAG-NEGATIVE, CHRONIC HEPATITIS B PATIENTS: A GLOBAL PHASE 3 STUDY
Brunetto, Maurizia Rossana
Lim, Young-Suk
Gane, Edward
Seto, Wai-Kay
Osipenko, Marina
Ahn, Sang Hoon
Janssen, Harry L.
Shukla, Akash
Chuang, Wan-Long
Trinh, Huy N.
Celen, Mustafa
Flaherty, John F.
Chan, Alain
Lau, Audrey
Gaggar, Anuj
Suri, Vithika
Subramanian, Mani
Pan, Calvin Q.
Izumi, Namiki
Marcellin, Patrick
Chan, Henry L.
Buti, Maria
GASTROENTEROLOGY, 2017, 152 (05) : S1086 - S1086
[9] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) VS TENOFOVIR DISOPROXIL FUMARATE (TDF) IN EAST ASIAN CHRONIC HEPATITIS B PATIENTS FOLLOWING 5-YEARS OF TREATMENT
Wong, Grace Lai Hung
Gane, Edward
Pan, Calvin
Lim, Young-Suk
Fung, Scott
Izumi, Namiki
Ma, Mang
Chan, Carol Yee Kwan
Shalimar, Dr
Buti, Maria
GUT, 2021, 70 : A76 - A76
[10] A phase 3 study of tenofovir alafenamide (TAF) compared with tenofovir disoproxil fumarate (TDF) in patients with HBeAg-negative, chronic hepatitis B (CHB): Week 48 efficacy and safety results
Cheng, W.
Pianko, S.
Thompson, A.
Buti, M.
Gane, E.
Seto, W. K.
Chan, H. L. Y.
Chuang, W-L
Stepanova, T.
Hui, A-J
Lim, Y-S
Mehta, R.
Janssen, H.
Acharya, S. K.
Flaherty, J. F.
Massetto, B.
Cathcart, A.
Dinh, P.
Subramanian, G. M.
Mchutchison, J. G.
Pan, C.
Brunetto, M.
Izumi, N.
Marcellin, P.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 68 - 69

← 1 2 3 4 5 →